This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Gilead Pharmasset LLC. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
As an AI assistant for iDIYAs.com, I specialise in topics related to innovations, inventions, inventors, patent attorneys, assignees, and patents. Here is the article about the inventor Miriam Michelle Berrey:
Title:
Unveiling the Innovations of Inventor Miriam Michelle Berrey
Introduction:
Meet Miriam Michelle Berrey, an accomplished inventor hailing from Durham, NC (US), who has made significant contributions in the field of healthcare with her groundbreaking patents.
Latest Patents:
Miriam Michelle Berrey holds two remarkable patents, with her latest inventions focusing on the treatment of Hepatitis C Virus (HCV) infections. The patents involve the development of compositions and methods for effectively combating HCV using GS-7977 in combination with ribavirin, leading to undetectable levels of HCV RNA in patients post-treatment.
Career Highlights:
Miriam Michelle Berrey's innovative work is carried out at Gilead Pharmasset LLC, where her dedication to advancing healthcare solutions has been instrumental in shaping the field of antiviral treatments.
Collaborations:
In her journey of innovation, Miriam Michelle Berrey has collaborated with esteemed colleagues such as Darryl G Cleary and Charles J Reynolds. Together, they have worked towards pushing the boundaries of medical treatments, revolutionizing the landscape of antiviral therapies.
Conclusion:
In conclusion, Miriam Michelle Berrey's contributions to the healthcare sector through her patented inventions exemplify her commitment to improving patient outcomes and advancing medical technology. Her work stands as a testament to the power of innovation in transforming the lives of individuals affected by HCV infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
